Study guide
2.2 Obstructive Sleep Apnea, Cardiovascular & Metabolic Risk Stratification
Certified Ambulatory Surgery Nurse CNAMB
Track your progress as you read
Finished sections get a check mark.
1 CNAMB Exam Blueprint, Eligibility & Test Strategy
Current CNAMB Exam Facts, Eligibility & Blueprint
2 Chapter 1: Preoperative Health Assessment & Diagnostic Evaluation
1.1 Patient Health History, Physical Assessment & Medication Reconciliation 1.2 Laboratory, Diagnostic & Cardiac Data Review in Ambulatory Surgery 1.3 Allergy Screening, Sensitivity Identification & Latex Precautions
3 Chapter 2: Risk Stratification, Anesthesia Screening & Pre-Op Clearance
2.1 ASA Physical Status Classification & ASC Patient Candidacy Criteria 2.2 Obstructive Sleep Apnea, Cardiovascular & Metabolic Risk Stratification
4 Chapter 3: Ambulatory Surgical Care Planning & Infection Prophylaxis
3.1 Perioperative Nursing Diagnoses & Individualized Ambulatory Care Plans 3.2 Surgical Site Infection (SSI) Prevention Bundles & Prophylactic Antibiotic Timing
5 Chapter 4: Patient Education, Vulnerable Populations & Discharge Prep
4.1 Preoperative Patient & Escort Education, Fasting Guidelines & NPO Rules 4.2 Health Literacy, Language Access & Cultural/Spiritual Care 4.3 Pediatric & Geriatric Ambulatory Care
6 Chapter 5: Surgical Asepsis, Sterile Technique & OR Environment
5.1 Principles of Surgical Asepsis, Sterile Field Integrity & Traffic Control 5.2 Surgical Hand Antisepsis, Gowning, Gloving & Draping Standards 5.3 Ambulatory OR Environmental Controls: HVAC, Temperature, Humidity & Air Exchanges
7 Chapter 6: Patient Positioning, Equipment Safety & Intraoperative Monitoring
6.1 Surgical Positioning: Alignment, Pressure Injury Prevention & Nerve Protection 6.2 Safe Use of Electrosurgery Units (ESU), Surgical Lasers & Smoke Evacuation 6.3 Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional) 6.4 Surgical Counts, Specimen Management Protocols & Wound Classification 6.5 Intraoperative Medication, Solution & Fluid Safety 6.6 Implants, Explants, Radiation & Hazardous Materials
8 Chapter 7: Interdisciplinary Communication & Handoff Protocols
7.1 Structured Handoff Protocols: SBAR, IPASS & Care Transitions in the ASC 7.2 Universal Protocol, Time-Out Verification & Wrong-Site Surgery Prevention
9 Chapter 8: Clinical Documentation, Electronic Health Records & Informed Consent
8.1 Ambulatory Nursing Documentation Standards, Timelines & Legal Integrity 8.2 Informed Consent Verification, Patient Autonomy & Refusal of Care
10 Chapter 9: Phase I Postanesthesia Care & Complication Management
9.1 Phase I PACU Airway Management, Oxygenation & Hemodynamic Stabilization 9.2 Postoperative Pain Management & PONV Multimodal Protocols in the ASC 9.3 Emergent Postoperative Complications: Laryngospasm, Hemorrhage & Hypothermia
11 Chapter 10: Phase II Recovery, Discharge Criteria & Post-Discharge Safety
10.1 Aldrete Scoring, PADSS (Post-Anesthesia Discharge Scoring System) & Discharge Readiness 10.2 Patient & Escort Discharge Instructions, Home Care & Follow-Up
12 Chapter 11: Instrument Processing, Sterilization & Supply Management
11.1 Point-of-Use Treatment, Decontamination & Cleaning of Surgical Instruments 11.2 High-Level Disinfection, Steam Sterilization & Low-Temperature Methods 11.3 Sterilization Process Monitoring: Chemical/Biological Indicators & Sterile Storage
13 Chapter 12: Ambulatory Perioperative Emergencies
12.1 Malignant Hyperthermia: Presentation, Ryanodex/Dantrolene Protocol & ASC Preparedness 12.2 Local Anesthetic Systemic Toxicity (LAST): Recognition, Lipid Emulsion & Resuscitation 12.3 Surgical Suite Fires, Code Blue & Emergency Transfer/Evacuation in the ASC 12.4 Anaphylaxis, Hemorrhage, Age-Specific Arrest & Disaster Response
14 Chapter 13: Management of Personnel, Services, and Materials
13.1 ASC Staffing Models, Competency Verification & Rapid Turnover Coordination 13.2 Inventory Management, Surgeon Preference Cards & Cost-Containment Strategies 13.3 Medical Device Safety, Preventive Maintenance & Vendor Management 13.4 Product Evaluation, Recalls, PPE & Environmental Stewardship
15 Chapter 14: Legal Standards, Regulatory Framework & Professional Ethics
14.1 Nursing Scope of Practice, UAP Delegation & ANA/AORN Professional Standards 14.2 Ethics in Ambulatory Care: Patient Advocacy, Confidentiality (HIPAA) & Mandatory Reporting 14.3 Competence, Bias, Civility & Evidence-Based Practice
16 Chapter 15: Quality Improvement, Accreditation & Evidence-Based Practice
15.1 ASC Accreditation Standards: AAAHC, The Joint Commission & CMS Conditions for Coverage 15.2 Quality Improvement, Infection Surveillance (NHSN), Incident Reporting & Root Cause Analysis 15.3 Certification Value, Professional Growth & Lifelong Learning (CCI CNAMB Maintenance)
2.2 Obstructive Sleep Apnea, Cardiovascular & Metabolic Risk Stratification
Key Takeaways Explain This Topic AI
The validated STOP-BANG questionnaire stratifies obstructive sleep apnea (OSA) risk; scores of 5 to 8 (or specific high-risk score combinations) identify patients at high risk for perioperative airway obstruction, hypoxemia, and opioid-induced respiratory depression.
Patients with diagnosed or high-risk OSA undergoing ambulatory surgery must bring their prescribed, functional CPAP/BiPAP machine on the day of surgery, while surgical teams prioritize regional techniques, multimodal non-opioid analgesia, and extended Phase II PACU monitoring.
Functional capacity below 4 METs or unknown capacity prompts structured perioperative risk assessment; cardiac testing or consultation is used selectively when the result would change management, not as an automatic requirement.
Active cardiovascular disease and recent PCI require team-based planning. Current guidance generally delays elective surgery at least 12 months after drug-eluting stent placement for acute coronary syndrome and at least 6 months after placement for chronic coronary disease when antiplatelet interruption is needed.
Preoperative diabetic management in the ASC targets fasting blood glucose between 100 and 180 mg/dL and HbA1c < 8.0%; morning management requires holding prandial insulin, reducing basal insulin to 50%–75%, and holding SGLT2 inhibitors for 3 to 4 days prior to surgery to prevent euglycemic diabetic ketoacidosis.
Last updated: September 2026
Obstructive Sleep Apnea (OSA) Screening: The STOP-BANG Instrument
Obstructive Sleep Apnea (OSA) is a common, underdiagnosed sleep-related breathing disorder characterized by repetitive partial (hypopnea) or complete (apnea) collapse of the upper airway during sleep, resulting in arterial hypoxemia, hypercapnia, and frequent micro-arousals. In the ambulatory surgical population, undiagnosed or severe OSA presents profound perioperative dangers. General anesthetics, sedatives, and systemic opioids cause pharyngeal muscle relaxation, depress central ventilatory drive, and impair arousal reflexes, dramatically amplifying airway collapsibility.
Patients with unrecognized or poorly managed OSA face significantly higher rates of difficult mask ventilation, failed intubation, postanesthetic laryngospasm, severe desaturation, unplanned endotracheal re-intubation, myocardial ischemia, and fatal respiratory arrest in the Post-Anesthesia Care Unit (PACU) or at home.
The STOP-BANG Questionnaire
To rapidly and reliably identify patients at risk for OSA during preoperative screening, ambulatory surgical centers utilize the STOP-BANG questionnaire , an 8-item, scoring instrument validated by the Society of Anesthesia and Sleep Medicine and the American Society of Anesthesiologists (ASA):
S – Snoring: Do you snore loudly (loud enough to be heard through closed doors, or your bed partner elbows you for snoring at night)?
T – Tiredness: Do you often feel tired, fatigued, or sleepy during daytime (such as falling asleep while driving, watching television, or talking)?
O – Observed Apnea: Has anyone observed you stop breathing, choking, or gasping during your sleep?
P – Blood Pressure: Do you have or are you currently being treated for high blood pressure (arterial hypertension)?
B – Body Mass Index (BMI): Is your Body Mass Index greater than 35 kg/m² ?
A – Age: Are you older than 50 years of age ?
N – Neck Circumference: Is your neck circumference greater than 17 inches (43 cm) for men, or greater than 16 inches (41 cm) for women? (Measured at the level of the cricothyroid membrane).
G – Gender: Are you of male gender ?
STOP-BANG Scoring Interpretation and Risk Stratification
Each positive response scores 1 point (total score range: 0 to 8 points):
Low Risk of OSA: Total score of 0 to 2 points . High negative predictive value; patient can proceed with standard ambulatory anesthetic protocols.
Intermediate Risk of OSA: Total score of 3 to 4 points . Moderate risk; warrants proactive airway planning, regional anesthesia preference, and cautious opioid titration.
High Risk of OSA: Total score of 5 to 8 points .
Alternative High-Risk Criteria: A patient also classifies as High Risk if they answer "Yes" to 2 or more of the 4 STOP questions PLUS meet at least one of three specific demographic thresholds:
- Male gender (STOP ≥ 2 + Male)
- BMI > 35 kg/m² (STOP ≥ 2 + BMI > 35)
- Neck circumference > 17 inches in men or > 16 inches in women (STOP ≥ 2 + Neck)
STOP-BANG Category Score Range / Combination Clinical Interpretation Ambulatory Surgery Implications
Low Risk 0 – 2 points Low probability of moderate-to-severe OSA Standard perioperative monitoring and discharge pathways
Intermediate Risk 3 – 4 points Moderate probability of OSA Multi-modal analgesia; avoid high-dose opioids; pre-op airway assessment
High Risk 5 – 8 points, OR (STOP ≥ 2 + Male), OR (STOP ≥ 2 + BMI > 35), OR (STOP ≥ 2 + Neck) High probability of severe OSA Mandatory CPAP machine on day of surgery; regional anesthesia preferred; continuous capnography; extended PACU recovery
Ambulatory Anesthetic & PACU Management for OSA Patients
The Society for Ambulatory Anesthesia (SAMBA) consensus guidelines emphasize that diagnosed or high-risk OSA is not an absolute contraindication to freestanding ambulatory surgery, provided the patient's comorbid systemic diseases (e.g., heart failure, pulmonary hypertension) are optimized and specific airway safety protocols are strictly enacted.
Preoperative Protocols
CPAP Machine Compliance: Patients with established OSA treated with Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP) must be instructed during the preoperative phone assessment to bring their personal CPAP/BiPAP device, power cords, tubing, and mask to the ASC on the day of surgery .
The ambulatory nurse inspects the machine upon arrival, confirms that the settings match the prescribed therapeutic pressures, and ensures that biomedical engineering check-in (or facility electrical safety inspection) is completed if required by facility policy.
The device is placed at the patient's bedside in the preoperative bay and transferred directly with the patient to the PACU.
Intraoperative Anesthetic Strategies
Anesthetic Technique Preference: Regional, neuraxial (spinal/epidural), or peripheral nerve blocks are strongly preferred over general anesthesia. When peripheral nerve blocks are employed, supplemental intravenous sedation should be minimized to avoid loss of pharyngeal muscle tone.
Airway Management: If general anesthesia is unavoidable, endotracheal intubation with a cuffed tube is generally preferred over a supraglottic airway (LMA) in high-risk patients with difficult airway anatomy. Video laryngoscopy should be immediately available.
Multimodal Opioid-Sparing Analgesia: High-dose systemic opioids act synergistically with residual volatile anesthetics to induce central apnea and upper airway collapse. Anesthesia providers utilize non-opioid analgesics: intravenous acetaminophen (1,000 mg IV), nonsteroidal anti-inflammatory drugs (ketorolac 15–30 mg IV or celecoxib 200 mg PO pre-op), dexamethasone (4–8 mg IV for both anti-inflammatory pain reduction and PONV prophylaxis), and surgical site local anesthetic infiltration.
Complete Neuromuscular Blockade Reversal: Residual neuromuscular weakness severely exacerbates airway obstruction. Objective quantitative train-of-four (TOF) monitoring must demonstrate a TOF ratio > 0.9 before extubation. Sugammadex is preferentially utilized for rapid, complete reversal of rocuronium or vecuronium-induced neuromuscular blockade.
Postoperative PACU Recovery Standards
Patient Positioning: Patients must never be placed flat supine during recovery. Elevate the head of the bed to 30 to 45 degrees ( semi-Fowler position ) or place the patient in a lateral recovery position to maintain gravitational forward displacement of the tongue and soft palate.
Immediate Postoperative CPAP: If the patient was using CPAP at home or exhibits snoring, airway obstruction, or oxygen desaturation upon emergence, apply their personal CPAP machine immediately in Phase I PACU.
Extended Phase II PACU Monitoring: High-risk OSA patients must remain in the ASC under continuous pulse oximetry and capnography monitoring for an extended period—typically at least 60 to 120 minutes longer than conventional patients , and for a minimum of 60 minutes after the last administration of any intravenous or parenteral opioid.
Discharge Readiness: The patient must demonstrate the ability to maintain baseline oxygen saturation (SpO2 ≥ 92%–94% on room air, or at their documented home oxygen baseline) while resting quietly in an unaroused, sleep-like state . If a patient experiences recurrent respiratory depression, severe oxygen desaturation (<90% despite supplemental oxygen), or frequent obstructive episodes requiring vigorous physical stimulation, the nurse must halt discharge and initiate transfer to an acute care hospital for continuous overnight monitoring.